Related Experiment Video
Updated: Jun 5, 2025

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel
Published on: June 29, 2015
Mendelian randomization assessing causal relationship between fibrinogen levels and ischemic stroke
Gie Ken-Dror1, Tanya Khanna1, Emily Hills1
1Institute of Cardiovascular Research, Royal Holloway University of London (ICR2UL), London TW20 0EX, UK.
Objective:
High fibrinogen levels are associated with an increased risk of ischaemic stroke (IS). We used mendelian randomisation (MR) to explore a potential causal relationship.
Materials And Methods:
Data for assessing the relationship between gene variant, disease and biological levels needed for a MR approach was collected using a meta-analytical approach. Inverse-variance weighted (IVW) approach was used for the main analyses and alternative approach for sensitivity analyses. The relationship between fibrinogen levels and IS was assessed using Odds Ratio (OR), while mean difference (g/L) was used for the relationship between SNP (rs1800790) and fibrinogen levels.
Results:
The variant FGB rs1800790 SNP was interrogated as an instrumental variable of fibrinogen levels. A meta-analysis with 24 studies (12 case-control and 12 cohort studies, totalling 20,902 cases and 76,510 controls was conducted. Homozygotes (AG) of rs1800790 have 0.14g/L (95%CI: 0.08-0.19, P<0.001) and minor allele (AA) have 0.18g/L (95%CI: 0.01-0.35, P=0.037) higher levels of plasma fibrinogen concentration compared with homozygous for the major allele (GG). The risk of IS was significantly increased in 1-g/L (OR=1.83, 95%CI: 0.92-3.62, P=0.084), or 1-SD of fibrinogen levels (OR=1.39, 95%CI: 1.03-1.87, P=0.030), or above median levels (OR=1.22, 95%CI: 1.02-1.46, P=0.029) or categorical levels tertiles (OR=1.50, 95%CI: 1.26-1.79, P<0.001). Each 1-g/L increase in fibrinogen levels was causally associated with a higher risk of ischemic stroke (OR=2.28, 95%CI: 1.53-3.03, P<0.001) in the Mendelian randomisation analysis.
Conclusions:
Elevated fibrinogen levels are a causative risk factor for ischaemic stroke with each 1g/L increase doubling its risk.
Insights
High fibrinogen levels significantly increase the risk of ischemic stroke (IS). Mendelian randomization confirmed that elevated fibrinogen is a causal factor, with each 1g/L rise potentially doubling stroke risk.
Area of Science:
- Cardiovascular Genetics
- Neurology
- Thrombosis Research
Background:
- Elevated plasma fibrinogen levels are a known risk factor for ischemic stroke (IS).
- The causal relationship between fibrinogen and IS requires further investigation using robust genetic methods.
Purpose of the Study:
- To investigate the potential causal relationship between plasma fibrinogen levels and the risk of ischemic stroke (IS) using Mendelian randomization (MR).
Main Methods:
- A Mendelian randomization (MR) approach was employed using meta-analytically derived data.
- The FGB rs1800790 single nucleotide polymorphism (SNP) served as an instrumental variable for fibrinogen levels.
- Inverse-variance weighted (IVW) methods were used for primary analyses, with sensitivity analyses performed using alternative approaches.
Main Results:
- A meta-analysis of 24 studies (20,902 cases, 76,510 controls) confirmed that the FGB rs1800790 SNP is a valid instrumental variable.
- Individuals with specific genotypes (AG and AA) of rs1800790 exhibited significantly higher plasma fibrinogen concentrations compared to GG homozygotes.
- Mendelian randomization analysis revealed a significant causal association between elevated fibrinogen levels and an increased risk of IS, with each 1 g/L increase in fibrinogen causally linked to a higher risk.
Conclusions:
- Elevated plasma fibrinogen levels are confirmed as a causative risk factor for ischemic stroke (IS).
- Each 1 g/L increase in fibrinogen concentration is associated with a substantial increase in IS risk, highlighting its clinical significance.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis

